The Journal of Pediatrics
Volume 154, Issue 5 , Pages 638-644 , May 2009

Metabolomics: A New Frontier for Research in Pediatrics

  • Silvia Carraro, MD

      Affiliations

    • Department of Pediatrics, University of Padova, Padova, Italy
    • ,
  • Giuseppe Giordano, PhD

      Affiliations

    • Department of Pediatrics, University of Padova, Padova, Italy
    • European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Physical and Chemical Exposure Unit, Ispra (VA), Italy
    • ,
  • Fabiano Reniero, PhD

      Affiliations

    • European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Physical and Chemical Exposure Unit, Ispra (VA), Italy
    • ,
  • Giorgio Perilongo, MD

      Affiliations

    • Department of Pediatrics, University of Padova, Padova, Italy
    • ,
  • Eugenio Baraldi, MD

      Affiliations

    • Department of Pediatrics, University of Padova, Padova, Italy
    • Corresponding Author InformationReprint requests: Dr Eugenio Baraldi, Department of Pediatrics, Allergy and Respiratory Medicine Unit, University of Padova, Via Giustiniani 3, 35128 Padova, Italy

Received 5 May 2008 ,Revised 17 November 2008 ,Accepted 9 January 2009.

References 

  1. Sauer U, Heinemann M, Zamboni N. Genetics: getting closer to the whole picture. Science. 2007;316:550–551
  2. Nicholson JK, Wilson ID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003;2:668–676
  3. Schnackenberg LK, Beger RD. Monitoring the health to disease continuum with global metabolic profiling and systems biology. Pharmacogenomics. 2006;7:1077–1086
  4. Hegde PS, White IR, Debouck C. Interplay of transcriptomics and proteomics. Curr Opin Biotechnol. 2003;14:647–651
  5. Nicholson J. Global system biology, personalized medicine and molecular epidemiology. Mol Syst Biol. 2006;2:52
  6. Ryan D, Robards K. Metabolomics: the greatest omics of them all?. Anal Chem. 2006;78:7954–7958
  7. Goodacre R. Metabolomics of a superorganism. J Nutr. 2007;137:259S–266S
  8. Nicholson JK, Holmes E, Lindon JC, Wilson ID. The challenges of modeling mammalian biocomplexity. Nat Biotechnol. 2004;22:1268–1274
  9. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2007;26:51–78
  10. Roe C, Millington D, Maltby D. Identification of 3-methylglutarylcarnitine: a new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J Clin Invest. 1986;77:1391–1394
  11. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007;35:D521–D526
  12. Issaq H, Abbott E, Veenstra T. Utility of separation science in metabolomic studies. J Sep Sci. 2008;31:1936–1947
  13. Lindon JC, Holmes E, Nicholson JK. So what's the deal with metabonomics?. Anal Chem. 2003;75:384A–391A
  14. Lindon J, Holmes E, Nicholson J. Pattern recognition methods and applications in biomedical magnetic resonance. Prog Nucl Magnetic Reson Spectrosc. 2001;39:1–40
  15. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004;32:D277–D280
  16. Krummenacker M, Paley S, Mueller L, Yan T, Karp P. Querying and computing with BioCyc databases. Bioinformatics. 2005;21:3454–3455
  17. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de Bono B, et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2005;33:D428–D432
  18. Smith C, O'Maille G, Want E, Qin C, Trauger S, Brandon T, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27:747–751
  19. Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, Holmes E. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst. 2003;128:32–36
  20. Holmes E, Leng R, Stamler J, Bictash M, Yap I, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008;493:396–401
  21. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005;112:3868–3875
  22. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med. 2002;8:1439–1444
  23. Kirschenlohr HL, Griffin JL, Clarke SC, Rhydwen R, Grace AA, Schofield PM, et al. Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med. 2006;12:705–710
  24. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest. 2008;118:3503–3512
  25. Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, et al. FinnDiane Study Group Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. MAGMA. 2006;19:281–296
  26. Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, et al 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol. 2008;4:167
  27. Wang C, Kong H, Guan Y, Yang J, Gu J, Yang S, et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem. 2005;77:4108–4116
  28. Yuan K, Kong H, Guan Y, Yang J, Xu G. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850:236–240
  29. Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrell T. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin Infect Dis. 2005;41:1582–1590
  30. Dunne VG, Bhattachayya S, Besser M, Rae C, Griffin JL. Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study. NMR Biomed. 2005;18:24–33
  31. Ghauri FY, Nicholson JK, Sweatman BC, Wood J, Beddell CR, Lindon JC, et al. NMR spectroscopy of human post mortem cerebrospinal fluid: distinction of Alzheimer's disease from control using pattern recognition and statistics. NMR Biomed. 1993;6:163–167
  32. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007;6:546–551
  33. Foxall PJ, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int. 1993;43:234–245
  34. Le Moyec L, Pruna A, Eugène M, Bedrossian J, Idatte JM, Huneau JF, et al. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron. 1993;65:433–439
  35. Serkova NJ, Zhang Y, Coatney JL, Hunter L, Wachs ME, Niemann CU, et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation. 2007;83:517–521
  36. Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer. 2005;113:782–788
  37. Yang J, Xu G, Zheng Y, Kong H, Pang T, Lv S, et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;813:59–65
  38. Issaq H, Nativ O, Waybright T, Luke B, Veenstra T, Issaq E, et al. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry. J Urol. 2008;179:2422–2426
  39. Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006;66:10795–10804
  40. Sitter B, Bathen T, Hagen B, Arentz C, Skjeldestad FE, Gribbestad IS. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. MAGMA. 2004;16:174–181
  41. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res. 1999;19:1737–1746
  42. Florian CL, Preece NE, Bhakoo KK, Williams SR, Noble M. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed. 1995;8:253–264
  43. Wikoff W, Gangoiti J, Barshop B, Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem. 2007;53:2169–2176
  44. Kawashima H, Oguchi M, Ioi H, Amaha M, Yamanaka G, Kashiwagi Y, et al. Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci. 2006;116:927–936
  45. Carraro S, Rezzi S, Reniero F, Héberger K, Giordano G, Zanconato S, et al. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2007;175:986–990
  46. Horváth I, Hunt J, Barnes PJ ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26:523–548
  47. Anderson G. Endotyping asthma: new insights into key pathogenetic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107–1119
  48. de Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, et al. Metabonomic analysis of exhaled breath condensate in adults by NMR spectroscopy. Eur Respir J. 2008;32:1175–1183
  49. Beger R, Holland R, Sun J, Schnackenberg L, Moore P, Dent C, et al. Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol. 2008;23:977–984
  50. Bertram HC, Hoppe C, Petersen BO, Duus JØ, Mølgaard C, Michaelsen KF. An NMR-based metabonomic investigation on effects of milk and meat protein diets given to 8-year-old boys. Br J Nutr. 2007;97:758–763
  51. Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, et al. Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006;5:2780–2788
  52. Solanky KS, Bailey NJ, Beckwith-Hall BM, Bingham S, Davis A, Holmes E, et al. Biofluid 1H NMR-based metabonomic techniques in nutrition research: metabolic effects of dietary isoflavones in humans. J Nutr Biochem. 2005;16:236–244
  53. Walsh MC, Brennan L, Pujos-Guillot E, Sébédio JL, Scalbert A, Fagan A, et al. Influence of acute phytochemical intake on human urinary metabolomic profiles. Am J Clin Nutr. 2007;86:1687–1693
  54. Law W, Huang P, Ong E, Ong C, Li S, Pasikanti K, et al. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. Rapid Commun Mass Spect. 2008;22:2436–2446
  55. Zeisel SH, Freake HC, Bauman DE, Bier DM, Burrin DG, German JB, et al. The nutritional phenotype in the age of metabolomics. J Nutr. 2005;135:1613–1616
  56. Hannon T, Dimeglio L, Pfefferkorn M, Denne S. Acute effect of enteral nutrition on protein turnover in adolescents with Crohn disease. Pediatr Res. 2007;61:356–360
  57. Reynolds R, Bass K, Thurrem P. Achieving positive protein balance in the immediate postoperative period in neonates undergoing abdominal surgery. J Pediatr. 2008;152:63–67
  58. Lindon JC, Holmes E, Nicholson JK. Metabonomics techniques and applications to pharmaceutical research and development. Pharm Res. 2006;23:1075–1088
  59. Keun HC. Metabonomic modeling of drug toxicity. Pharmacol Ther. 2006;109:92–106
  60. van Doorn M, Vogels J, Tas A, van Hoogdalem EJ, Burggraaf J, Cohen A, et al. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol. 2007;63:562–574
  61. Hewer R, Vorster J, Steffens FE, Meyer D. Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals. J Pharm Biomed Anal. 2006;41:1442–1446
  62. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature. 2006;440:1073–1077
  63. Li H, Ni Y, Su M, Qiu Y, Zhou M, Qiu M, et al. Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats. J Proteome Res. 2007;6:1364–1370
  64. Kochhar S, Jacobs DM, Ramadan Z, Berruex F, Fuerholz A, Fay LB. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem. 2006;352:274–281
  65. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, et al. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem. 2007;79:6995–7004
  66. Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal. 2003;33:1103–1115
  67. Lenz EM, Bright J, Wilson ID, Hughes A, Morrisson J, Lindberg H, et al. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J Pharm Biomed Anal. 2004;36:841–849
  68. Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr. 2006;84:531–539
  69. Beckonert O, Keun H, Ebbels T, Bundy J, Holmes E, Lindon J, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nature protocols. 2007;11:2692–2703
  70. Fiehn O, Robertson D, Griffin J, van der Werf M, Nikolau B, Morrison N, et al. The metabolomics standard initiative (MSI). Metabolomics. 2007;3:175–178

 The authors declare no potential conflicts of interest.

PII: S0022-3476(09)00017-1

doi: 10.1016/j.jpeds.2009.01.014

The Journal of Pediatrics
Volume 154, Issue 5 , Pages 638-644 , May 2009

Article Tools

* Image Usage & Resolution